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1. Introduction
Hypercholesterolemia is one of the major risk factors of atherosclerotic disease. Treatment with
statins reduces serum levels of low-density lipoprotein cholesterol, and attenuates athero‐
sclerotic plaque formation in the carotid artery, coronary artery, and thoracic aorta.
During diagnostic angiography or interventions for coronary artery diseases, catheterization
can lead to devastating complications, including stroke. Previous studies reported stroke rates
of 0.1–0.4% [1-9]. Catheterization-related acute stroke is associated with high in-hospital
mortality and prevalence of overall major complications [5,10,11].
Because only new neurological complications are classified as stroke, clinically unapparent
cerebral embolisms are not taken into account. Asymptomatic cerebral infarction is thought to
be related to the incidence of symptomatic cerebral infarction, cognitive decline, and demen‐
tia [12], and may thus represent a significant complication of catheterization procedures.
Here, we summarize our review of published literature, present two case studies in our
cardiovascular center, and summarize our data on hypercholesterolemia and catheterization-
related stroke.
2. A review of published literature on hypercholesterolemia and
catheterization-related stroke
Previously published data on catheterization-related acute stroke is summarized in Figure
1. Previous studies have reported stroke rates of 0.1– 0.4% [1-9], and rates of stroke and
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transient ischemia attack (TIA) after catheterization do not appear to have decreased over
time (Figure 1). Much of the published data is limited to stroke. Stroke is defined as cerebral
infarction or hemorrhage with a neurological  deficit  lasting >24 h;  TIA is a neurological
deficit lasting <24 h.
Figure 1. Rates of stroke and transient ischemic attack (TIA) after catheterization have not reduced overtime [1-9].
Magnetic resonance imaging (MRI) can be used to detect asymptomatic cerebral infarction
related to catheterization. Diffusion-weighted MRI (DW-MRI), in particular, represents a
highly sensitive tool for detecting acute cerebral ischemic lesions [13,14]. New lesions appear
as focal high-intensity cerebral lesions on diffusion-weighted imaging (DWI) and have a low
signal on apparent diffusion coefficient (ADC) maps [15].
Several prospective studies of silent cerebral infarction have been performed in a small number
of patients. Bendszus et al. used DW-MRI before and after angiography of cerebral vessels to
assess embolic events in 100 consecutive angiographies (66 diagnostic and 34 interventional)
in 91 patients [16]. In their report, published in The Lancet in 1999, they showed that 23% of
procedures caused silent embolic cerebral infarction: 42 bright lesions were observed in 23
patients after 23 procedures (17 diagnostic, six interventional), in a pattern consistent with
embolic events, and in the absence of any new neurological deficit. More contrast medium, a
longer fluoroscopy time, more frequent additional catheters, and having more vessels that
were difficult to approach were the risks of silent embolic cerebral infarction. Patients’ mean
age did not differ between patients with lesions and those without lesions, but their mean age
was relatively young (around 50 years old) compared to patients who are receiving cardiac
catheterization.
Lund et al. monitored cerebral microemboli during catheterization in 42 unselected patients
using multifrequency transcranial Doppler alongside cerebral DW-MRI and neuropsycholog‐
ical assessments. Measurements were taken on the days before and after catheterization [17].
Their report, published in the European Heart Journal in 2005, showed that new cerebral lesions
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were present in 15.2% of transradial catheterization patients, but in none of the transfemoral
catheterization patients. These lesions were significantly associated with a higher number of
solid microemboli and a longer fluoroscopy time. Approximately 80% of patients were male
and had hyperlipidemia or were statin users; approximately 40% of patients had a previous
history of myocardial infarction.
In 2005, Karen et al., using MRI before and after catheterization procedures, reported focal
cerebral infarction without any symptoms in 15% of 48 patients [18]. In this prospective study,
definitive conclusions could not be drawn owing to the small sample size, but procedure
duration appeared to predict cerebral infarction following catheterization. Patients with
cerebral infarction were also found to have a history of smoking, hyperlipidemia, hyperten‐
sion, and obesity.
It is often difficult to acquire MR images before and after procedures in prospective studies.
In 2011, Kojuri et al. reported in BMC Cardiovascular Disorders the prevalence of retinal emboli
after diagnostic and therapeutic catheterization during retinal examination: 6.3% of 300
patients and only 1 patient developed vision disorder [19].
Patients who undergo aortic stenosis (AS) procedures that involve crossing of the aortic valve
carry a high risk of cerebral infarction. In 2003, Omran et al. reported in the Lancet that 22% of
101 AS patients undergoing retrograde catheterization of the left ventricle had new lesions on
MRI, and 3 patients had symptomatic cerebral infarction [20]. A total of 152 patients with AS
undergoing cardiac catheterization were randomized to receive catheterization with or
without retrograde passage of the aortic valve in a ratio of 2:1. An additional 32 patients
without AS were also assessed as healthy controls. In patients without retrograde passage of
the aortic valve, and in healthy controls, there was no MRI or clinical evidence of cerebral
embolism.
Although these studies used relatively small sample sizes, the incidence of asymptomatic
cerebral infarction following catheterization, as assessed by MRI or other methods, appears to
remain relatively high. Following improvements in catheter design (rendering them more
slender) and in techniques, catheterization-related cerebral infarctions were expected to
decrease, though this may be counterbalanced by the increased risk profile of patients who
undergo catheterization.
3. Two cases of asymptomatic and symptomatic cerebral infarction related
to catheterization
Here we present two cases of cerebral infarction with and without symptoms which was
related to cardiac catheterization.
Case 1: A 73-year-old man with hyperlipidemia, hypertension and diabetes underwent
percutaneous coronary intervention (PCI) via the right radial artery. An initial diagnostic
procedure was performed using 4F catheter; a 6F catheter was subsequently used to perform
PCI for the left anterior descending artery (LAD). Due to the tortuosity of the LAD, the
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procedure time was 58 min and 275 ml contrast medium was used. MRI was performed 5 days
later for MR angiography to detect carotid and intra-cranial lesions. MRI was not performed
prior to the procedure; however, new lesions appeared as focal high-intensity cerebral lesions
on DWI (Figure 2A) and gave a low signal on ADC maps (Figure 2B). ADC maps represent a
useful tool for detecting acute ischemic infarct lesions [16].
Case 2: A 69-year-old woman with hyperlipidemia and diabetes underwent diagnostic
catheterization for left ventricular systolic dysfunction of unknown etiology, with 45% ejection
fraction. On the day after catheterization, the patient complained of dizziness. DW-MRI
revealed a spotty high-intensity signal (Figure 2C).
Figure 2. Magnetic resonance imaging (MRI) in two cases of asymptomatic and symptomatic cerebral infarction relat‐
ed to catheterization. (A) Diffusion-weighted MR image of Case 1. (B) Apparent diffusion coefficient (AMC) map of
Case 1. (C) DW-MR image of Case 2.
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4. A single center retrospective analysis of catheterization-related cerebral
infarction
We next present the summarized results of a single center analysis of catheterization-related
cerebral infarction in our cardiovascular center. A total of 84 patients who had undergone 1237
consecutive catheterizations with follow-up MRI within 14 days, between 2010 and 2011, were
retrospectively analyzed. Of these, 10 symptomatic patients underwent MRI to check for
cerebral infarction. The remaining 74 patients were asymptomatic, and underwent MRI for
preliminary assessment before coronary artery bypass graft (35%), valvular surgery (18%), or
aortic repair (6.8%). MRI revealed cerebral infarction in 5 out of 10 symptomatic patients (50%),
and in 22 out of 74 asymptomatic patients (29.7%). Patient background characteristics are
presented in Tables 1 and 2. In univariate analysis, the prevalence of dyslipidemia, the number
of atherosclerotic risk factors, the number of catheters used, the procedure time, urgent
settings, and reasons for intervention differed significantly between patients with and without
cerebral infarction (Tables 1 and 2). Dyslipidemia and the number of catheters used were
identified as predictive of catheterization-related cerebral infarction by multivariate analysis
(odds ratio [OR], 4.66; 95% CI, 1.32−20.2; P=0.02 and OR, 2.04; 95% CI 1.02−4.35; P=0.04,
respectively). Overall, the rate of asymptomatic catheterization-related cerebral infarction
detected by DW-MRI was high (29.7%). This may be partially due to selection bias because
MRI was performed in candidates for cardiac surgery for atherosclerotic disease. The rate of
catheterization-related symptomatic ischemic stroke recorded in this study (0.24%) is roughly
equivalent to those reported in previous studies [1-9].
Infarction group No infarction group P value
(n=27) (n=57)
Age, yr 74.1±6.6 70.4±9.4 0.08
Male, % 66.7 59.6 0.54
Risk factors
Hypertension, % 77.8 71.9 0.57
Dyslipidemia, % 81.5 52.6 0.01
Diabetes, % 55.6 36.8 0.11
Smoking, % 63 57.9 0.66
Family history, % 29.6 15.8 0.14
No. of risk factors 3.03±1.26 2.32±1.19 0.014
Table 1. Baseline characteristics
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Infarction group No infarction group P value
(n=27) (n=57)
No. of catheters used 2.85±1.1 2.12±0.9 0.003
Catheter size, F 4.44±0.8 4.25±0.6 0.3
Contrast volume, ml 128±55 120±55 0.48
Fluoroscopy time, min 22.7±14 17.1±12 0.04
LV angiogram, % 48.2 43.9 0.71
Aortic angiogram, % 11.1 14 0.71
Urgent, % 22.2 7 0.04
IABP, % 3.7 0 0.14
Purpose of procedure
Diagnostic, % 74.1 91.2 0.04
Interventional, % 25.9 8.8 0.04
Approach site
Radial or brachial, % 81.5 80.7 0.93
Femoral, % 18.5 19.3 0.93
Table 2. Procedural characteristics
5. Conclusions
Despite improvements in procedural techniques and catheter design, patients undergoing
catheterization remain at greater risk of atherosclerosis. While ischemic or hemorrhagic stroke
is the most debilitating complication of such procedures, conferring significant comorbidity
and mortality, asymptomatic cerebral infarction, which has been associated with cognitive
decline, is also a significant complication. Intervention against atherosclerotic risk factors is
needed along with careful procedural planning, in order to reduce rates of catheterization-
related cerebral infarction. Hypercholesterolemia is one of risks of catheterization-related
cerebral infarction.
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